UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes

Journal of virology, 2016-11, Vol.90 (22), p.10145-10159

2016

Volltextzugriff (PDF)

Role of CCR2 Genotype in the Clinical Course of Syncytium-Inducing (SI) or Non-SI Human Immunodeficiency Virus Type 1 Infection and in the Time to Conversion to SI Virus Variants

The Journal of infectious diseases, 1998-12, Vol.178 (6), p.1806-1811

1998

Volltextzugriff (PDF)

The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection

AIDS (London), 1998-06, Vol.12 (9), p.F85-F90

1998

Volltextzugriff (PDF)

Adaptation to Promiscuous Usage of Chemokine Receptors Is Not a Prerequisite for Human Immunodeficiency Virus Type 1 Disease Progression

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1106-1115

1999

Volltextzugriff (PDF)

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

The Journal of clinical investigation, 2000-10, Vol.106 (8), p.1039-1052

2000

Volltextzugriff (PDF)

Small RNAs and the control of transposons and viruses in Drosophila

Trends in microbiology (Regular ed.), 2009-04, Vol.17 (4), p.163-171

2009

Volltextzugriff (PDF)

The silent treatment: RNAi as a defense against virus infection in mammals

Trends in biotechnology (Regular ed.), 2006-04, Vol.24 (4), p.186-193

2006

Volltextzugriff (PDF)

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

The Journal of clinical investigation, 2000-12, Vol.106 (12), p.1569-1569

2000

Volltextzugriff (PDF)

RNA silencing in viral infections: insights from poliovirus

Virus research, 2004-06, Vol.102 (1), p.11-17

2004

Volltextzugriff (PDF)

In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists

Journal of Virology, 2004-03, Vol.78 (6), p.2722-2728

2004

Volltextzugriff (PDF)

Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus

Virology (New York, N.Y.), 2005-08, Vol.339 (1), p.70-80

2005

Volltextzugriff (PDF)

Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination

Virology (New York, N.Y.), 2003-09, Vol.314 (1), p.451-459

2003

Volltextzugriff (PDF)

Reduced Prevalence of the CCR5 Δ32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex

The Journal of infectious diseases, 1999-09, Vol.180 (3), p.854-857

1999

Volltextzugriff (PDF)

Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants

AIDS (London), 2003-05, Vol.17 (7), p.981-985

2003

Volltextzugriff (PDF)

CC chemokine receptor 5 delta 32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients

The Journal of infectious diseases, 2002-12, Vol.186 (12), p.1726-1732

2002

Volltextzugriff (PDF)

Cell turnover and cell tropism in HIV-1 infection

Trends in microbiology (Regular ed.), 2002-06, Vol.10 (6), p.275-278

2002

Volltextzugriff (PDF)

Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution

AIDS research and human retroviruses, 2003-05, Vol.19 (5), p.389-398

2003

Volltextzugriff (PDF)

Both R5 and X4 Human Immunodeficiency Virus Type 1 Variants Persist during Prolonged Therapy with Five Antiretroviral Drugs

Journal of Virology, 2002-03, Vol.76 (6), p.3054-3058

2002

Volltextzugriff (PDF)

Reduced Prevalence of the CCR5 Delta 32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex

The Journal of infectious diseases, 1999-09, Vol.180 (3), p.854-857

1999

Volltextzugriff (PDF)

Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants

AIDS (London), 2003-05, Vol.17 (7), p.981-985

2003

Volltextzugriff (PDF)

Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection

Antiviral therapy, 2003-04, Vol.8 (2), p.137-142

2003

Volltextzugriff (PDF)

Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen

Antiviral therapy, 2002-03, Vol.7 (1), p.37-41

2002

Volltextzugriff (PDF)

Host Genetic Factors in the Clinical Course of HIV-1 Infection: Chemokines and Chemokine Receptors

Community genetics, 2002, Vol.5 (2), p.88-101

2002

Volltextzugriff (PDF)

Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex

The Journal of infectious diseases, 1999-09, Vol.180 (3), p.854-857

1999

Volltextzugriff (PDF)

Early Viral Load and CD4 super(+) T Cell Count, But Not Percentage of CCR5 super(+) or CXCR4 super(+) CD4 super(+) T Cells, Are Associated with R5-to-X4 HIV Type 1 Virus, Evolution

AIDS research and human retroviruses, 2003-05, Vol.19 (5), p.389-398

2003

Volltextzugriff (PDF)

1 – 25 von 129

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(129)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA Interference Machinery and Determines West Nile Virus Transmission by Culex pipiens Mosquitoes

Role of CCR2 Genotype in the Clinical Course of Syncytium-Inducing (SI) or Non-SI Human Immunodeficiency Virus Type 1 Infection and in the Time to Conversion to SI Virus Variants

The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection

Adaptation to Promiscuous Usage of Chemokine Receptors Is Not a Prerequisite for Human Immunodeficiency Virus Type 1 Disease Progression

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

Small RNAs and the control of transposons and viruses in Drosophila

The silent treatment: RNAi as a defense against virus infection in mammals

Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1

RNA silencing in viral infections: insights from poliovirus

In Vivo Evolution of X4 Human Immunodeficiency Virus Type 1 Variants in the Natural Course of Infection Coincides with Decreasing Sensitivity to CXCR4 Antagonists

Natural controlled HIV infection: Preserved HIV-specific immunity despite undetectable replication competent virus

Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination

Reduced Prevalence of the CCR5 Δ32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex

Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants

CC chemokine receptor 5 delta 32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients

Cell turnover and cell tropism in HIV-1 infection

Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution

Both R5 and X4 Human Immunodeficiency Virus Type 1 Variants Persist during Prolonged Therapy with Five Antiretroviral Drugs

Reduced Prevalence of the CCR5 Delta 32 Heterozygous Genotype in Human Immunodeficiency Virus-Infected Individuals with AIDS Dementia Complex

Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants

Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection

Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen

Host Genetic Factors in the Clinical Course of HIV-1 Infection: Chemokines and Chemokine Receptors

Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex

Early Viral Load and CD4 super(+) T Cell Count, But Not Percentage of CCR5 super(+) or CXCR4 super(+) CD4 super(+) T Cells, Are Associated with R5-to-X4 HIV Type 1 Virus, Evolution

Suchergebnisse filtern